Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The neuroanatomy of Eml1 knockout mice, a model of subcortical heterotopia.
Collins SC, Uzquiano A, Selloum M, Wendling O, Gaborit M, Osipenko M, Birling MC, Yalcin B, Francis F. Collins SC, et al. Among authors: osipenko m. J Anat. 2019 Sep;235(3):637-650. doi: 10.1111/joa.13013. Epub 2019 Jun 7. J Anat. 2019. PMID: 31173351 Free PMC article.
Conditional switching of KIF2A mutation provides new insights into cortical malformation pathogeny.
Gilet JG, Ivanova EL, Trofimova D, Rudolf G, Meziane H, Broix L, Drouot N, Courraud J, Skory V, Voulleminot P, Osipenko M, Bahi-Buisson N, Yalcin B, Birling MC, Hinckelmann MV, Kwok BH, Allingham JS, Chelly J. Gilet JG, et al. Among authors: osipenko m. Hum Mol Genet. 2020 Mar 27;29(5):766-784. doi: 10.1093/hmg/ddz316. Hum Mol Genet. 2020. PMID: 31919497 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
First Measurement of Deeply Virtual Compton Scattering on the Neutron with Detection of the Active Neutron.
Hobart A, Niccolai S, Čuić M, Kumerički K, Achenbach P, Alvarado JS, Armstrong WR, Atac H, Avakian H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Benkel B, Benmokhtar F, Bianconi A, Biselli AS, Boiarinov S, Bondi M, Booth WA, Bossù F, Brinkmann KT, Briscoe WJ, Brooks WK, Bueltmann S, Burkert VD, Cao T, Capobianco R, Carman DS, Chatagnon P, Ciullo G, Cole PL, Contalbrigo M, D'Angelo A, Dashyan N, De Vita R, Defurne M, Deur A, Diehl S, Dilks C, Djalali C, Dupre R, Egiyan H, Alaoui AE, Fassi LE, Elouadrhiri L, Fegan S, Filippi A, Fogler C, Gates K, Gavalian G, Gilfoyle GP, Glazier D, Gothe RW, Gotra Y, Guidal M, Hafidi K, Hakobyan H, Hattawy M, Hauenstein F, Heddle D, Holtrop M, Ilieva Y, Ireland DG, Isupov EL, Jiang H, Jo HS, Joo K, Kageya T, Kim A, Kim W, Klimenko V, Kripko A, Kubarovsky V, Kuhn SE, Lanza L, Leali M, Lee S, Lenisa P, Li X, MacGregor IJD, Marchand D, Mascagna V, Maynes M, McKinnon B, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev V, Camacho CM, Nadel-Turonski P, Naidoo P, Neupane K, Niculescu G, Osipenko M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Pasyuk E, Paul SJ, Phelps W, Pilleux N, Pokhrel M, Rafael SP, Poud… See abstract for full author list ➔ Hobart A, et al. Among authors: osipenko m. Phys Rev Lett. 2024 Nov 22;133(21):211903. doi: 10.1103/PhysRevLett.133.211903. Phys Rev Lett. 2024. PMID: 39642503
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Hanauer SB, Sands BE, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P, Srećković S, Valuyskikh E, Lahat A, Horyński M, Gasbarrini A, Osipenko M, Borzan V, Kowalski M, Saenko D, Sardinov R, Lee SJ, Kim S, Bae Y, Lee S, Lee S, Lee JH, Yang S, Lee J, Lee J, Kim JM, Park G, Sandborn WJ, Colombel JF. Hanauer SB, et al. Among authors: osipenko m. Gastroenterology. 2024 Oct;167(5):919-933. doi: 10.1053/j.gastro.2024.05.006. Epub 2024 May 23. Gastroenterology. 2024. PMID: 38788861 Free article. Clinical Trial.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
First Measurement of Hard Exclusive π^{-}Δ^{++} Electroproduction Beam-Spin Asymmetries off the Proton.
Diehl S, Trotta N, Joo K, Achenbach P, Akbar Z, Armstrong WR, Atac H, Avakian H, Baashen L, Baltzell NA, Barion L, Bashkanov M, Battaglieri M, Bedlinskiy I, Benmokhtar F, Bianconi A, Biselli AS, Bossù F, Brinkmann KT, Briscoe WJ, Bulumulla D, Burkert V, Capobianco R, Carman DS, Carvajal JC, Celentano A, Charles G, Chatagnon P, Chesnokov V, Ciullo G, Cole PL, Contalbrigo M, Costantini G, Crede V, D'Angelo A, Dashyan N, De Vita R, Deur A, Djalali C, Dupre R, Ehrhart M, El Alaoui A, El Fassi L, Elouadrhiri L, Fegan S, Filippi A, Gavalian G, Glazier DI, Golubenko AA, Gosta G, Gothe RW, Gotra Y, Griffioen K, Hafidi K, Hakobyan H, Hattawy M, Hayward TB, Heddle D, Hobart A, Holtrop M, Illari I, Ireland DG, Isupov EL, Jo HS, Johnston R, Keller D, Khachatryan M, Khanal A, Kim A, Kim W, Klimenko V, Kripko A, Kubarovsky V, Kuhn SE, Lagerquist V, Lanza L, Leali M, Lee S, Lenisa P, Li X, MacGregor IJD, Marchand D, Mascagna V, Matousek G, McKinnon B, McLauchlin C, Meziani ZE, Migliorati S, Milner RG, Mineeva T, Mirazita M, Mokeev V, Moran P, Munoz Camacho C, Naidoo P, Neupane K, Niccolai S, Niculescu G, Osipenko M, Pandey P, Paolone M, Pappalardo LL, Paremuzyan R, Paul SJ, Phelps W, Pill… See abstract for full author list ➔ Diehl S, et al. Among authors: osipenko m. Phys Rev Lett. 2023 Jul 14;131(2):021901. doi: 10.1103/PhysRevLett.131.021901. Phys Rev Lett. 2023. PMID: 37505937 Free article.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
151 results